Chinese Journal of Antituberculosis ›› 2020, Vol. 42 ›› Issue (8): 761-768.doi: 10.3969/j.issn.1000-6621.2020.08.001
• Guideline·Standard·Consensus • Next Articles
Chinese Antituberculosis Association, Schools and Children Branch of the Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis
Received:
2020-06-12
Online:
2020-08-10
Published:
2020-08-10
Chinese Antituberculosis Association, Schools and Children Branch of the Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis . Expert consensus of clinical application of the recombinant Mycobacterium tuberculosis fusion protein (EC)[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 761-768. doi: 10.3969/j.issn.1000-6621.2020.08.001
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2020.08.001
患者分类 | 例数 | EC阳性 例数 | 敏感度 (%) | T-SPOT.TB 阳性例数 | 敏感度 (%) | TB-PPD 阳性例数 | 敏感度 (%) | 敏感度差值(95%CI)(%) | |
---|---|---|---|---|---|---|---|---|---|
EC和T-SPOT.TB | EC和TB-PPD | ||||||||
结核病患者 | 791 | 717 | 90.64 | 721 | 91.15 | 719 | 90.90 | -0.51 (-2.39~1.36) | -0.26 (-2.36~1.80) |
成人肺结核患者 | 667 | 608 | 91.15 | 616 | 92.35 | 608 | 91.15 | -1.20 (-3.22~0.75) | 0.00 (-2.25~2.25) |
菌阳肺结核患者 | 389 | 366 | 94.09 | 369 | 94.86 | 360 | 92.54 | -0.77 (-3.42~1.79) | 1.55 (-1.27~4.48) |
菌阴肺结核患者 | 278 | 242 | 87.05 | 247 | 88.85 | 248 | 89.21 | -1.80 (-4.81~1.40) | -2.16 (-5.77~1.42) |
初治肺结核患者 | 583 | 531 | 91.08 | 536 | 91.94 | 530 | 90.91 | -0.86 (-2.91~1.21) | 0.17 (-2.25~2.58) |
复治肺结核患者 | 84 | 77 | 91.67 | 80 | 95.24 | 78 | 92.86 | -3.57 (-10.11~2.35) | -1.19 (-6.70~4.00) |
成人肺外结核患者 | 198 | 186 | 93.94 | 188 | 94.95 | 181 | 91.41 | -1.01 (-3.54~1.44) | 2.53 (-1.11~6.35) |
成人单纯肺外结核病 | 69 | 63 | 91.30 | 63 | 91.30 | 64 | 92.75 | 0.00 (-4.17~4.29) | -1.45 (-7.97~4.92) |
儿童结核病患者 | 46 | 38 | 82.61 | 35 | 76.09 | 39 | 84.78 | 6.52 (-4.76~18.18) | -2.17 (-13.33~9.30) |
[1] | World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization, 2019. |
[2] | 全国结核病流行病学抽样调查技术指导组, 全国结核病流行病学抽样调查办公室. 2000年全国结核病流行病学抽样调查报告. 中国防痨杂志, 2002,24(2):65-108. |
[3] |
Houben RM, Dodd PJ. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med, 2016,13(10):e1002152. doi: 10.1371/journal.pmed.1002152.
doi: 10.1371/journal.pmed.1002152 URL pmid: 27780211 |
[4] |
Gao L, Lu W, Bai L, et al. Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study. Lancet Infect Dis, 2015,15(3):310-319. doi: 10.1016/S1473-3099(14)71085-0.
doi: 10.1016/S1473-3099(14)71085-0 URL pmid: 25681063 |
[5] | World Health Organization. WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment. Geneva: World Health Organization, 2020. |
[6] | 施雯慧, 成诗明, 陈伟. 结核潜伏性感染诊断研究进展. 疾病监测, 2012,27(3):78-83. doi: 10.3784/j.issn.1003-9961.2012.3.022. |
[7] |
American Thoracic Society. Targeted tuberculin testing and treatment of Latent Tuberculosis Infection. MMWR Recomm Rep, 2000,49(RR-6):1-51.
URL pmid: 10881762 |
[8] | World Health Organization. Global tuberculosis report 2015. Geneva: World Health Organization, 2015. |
[9] | 中华人民共和国国家卫生健康委员会. 中国结核病预防控制工作技术规范(2020年版). 国卫办疾控函〔2020〕279号.2020-04-02. |
[10] | 唐神结. 菌阴肺结核患者的临床特征. 中华结核和呼吸杂志, 2005,28(10):674-676. |
[11] | 中华人民共和国国家卫生和计划生育委员会.WS 288—2017 肺结核诊断. 2017-11-09. |
[12] | 蒋明娟, 刘思静, 汪川. 潜伏性结核感染诊断抗原研究进展. 现代预防医学, 2017,44(20):3837-3840. |
[13] | World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva: World Health Organization, 2018. |
[14] | 中华医学会结核病学分会儿童结核病专业委员会, 国家儿童医学中心, 首都医科大学附属北京儿童医院, 等. 儿童结核分枝杆菌潜伏感染筛查和预防性治疗专家共识. 中华结核和呼吸杂志, 2020,43(4):345-349. doi: 10.3760/cma.j.cn112147-20200106-00006. |
[15] | 全国结核病流行病学抽样调查领导小组. 1979年全国结核病流行病学抽样调查综合简报. 中华结核和呼吸系疾病杂志, 1982,5(2):67-70. |
[16] | 全国结核病流行病学抽样调查领导小组. 全国第二次结核病流行病学抽样调查综合简报. 中华医学杂志, 1990,70(5):291-291. |
[17] | 全国结核病流行病学抽样调查技术指导组, 全国结核病流行病学抽样调查办公室. 第三次全国结核病流行病学抽样调查报告. 中华结核和呼吸杂志, 1992,15(2):69-71. |
[18] |
Pai M, Denkinger CM, Kik SV, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev, 2014,27(1):3-20. doi: 10.1128/CMR.00034-13.
doi: 10.1128/CMR.00034-13 URL pmid: 24396134 |
[19] | 赵雁林. 结核病实验室诊断技术培训教程. 北京: 人民卫生出版社, 2014. |
[20] | 葛广秀, 邱美玲, 彭义利, 等. 结核菌素试验复强反应发生率及机理的探讨. 中国防痨杂志, 1995,17(4):173-175. |
[21] |
van Zyl-Smit RN, Pai M, Peprah K, et al. Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am J Respir Crit Care Med, 2009,180(1):49-58. doi: 10.1164/rccm.200811-1704OC.
doi: 10.1164/rccm.200811-1704OC URL pmid: 19342414 |
[22] | 缪海锋, 盛吉芳. 干扰素-γ释放试验(IGRA)在结核病诊断中的研究进展//中华医学会第十六次全国病毒性肝炎及肝病学术会议论文集.昆明,2013. 北京:中华医学会, 2013: 470. |
[23] |
Arlehamn CS, Sidney J, Henderson R, et al. Dissecting mechanisms of immunodominance to the common tuberculosis antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ). J Immunol, 2012,188(10):5020-5031. doi: 10.4049/jimmunol.1103556.
doi: 10.4049/jimmunol.1103556 URL pmid: 22504645 |
[24] | 刘二勇, 周林, 成诗明, 等. 结核分枝杆菌潜伏性感染及预防性治疗研究进展的系统评价. 中国防痨杂志, 2013,35(4):231-239. |
[25] | 《中国防痨杂志》编辑委员会, 中国医疗保健国际交流促进会结核病防治分会基础学组和临床学组. 现阶段结核抗体检测在我国临床应用的专家共识. 中国防痨杂志, 2018,40(1):9-13. doi: 10.3969/j.issn.1000-6621.2018.01.004. |
[26] |
Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest, 2007,131(6):1898-1906. doi: 10.1378/chest.06-2471.
doi: 10.1378/chest.06-2471 URL pmid: 17565023 |
[27] |
Chapman AL, Munkanta M, Wilkinson KA, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS, 2002,16(17):2285-2293. doi: 10.1097/00002030-200211220-00008.
doi: 10.1097/00002030-200211220-00008 URL pmid: 12441800 |
[28] |
Spencer JS, Kim HJ, Marques AM, et al. Comparative analysis of B- and T-cell epitopes of Mycobacterium leprae and Mycobacterium tuberculosis culture filtrate protein 10. Infect Immun, 2004,72(6):3161-3170. doi: 10.1128/IAI.72.6.3161-3170.2004.
doi: 10.1128/IAI.72.6.3161-3170.2004 URL pmid: 15155617 |
[29] |
Lewinsohn DM, Zhu L, Madison VJ, et al. Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity. J Immunol, 2001,166(1):439-446. doi: 10.4049/jimmunol.166.1.439.
doi: 10.4049/jimmunol.166.1.439 URL pmid: 11123322 |
[30] | 国家药典委员会. 中华人民共和国药典(2010年版三部). 北京: 中国医药科技出版社, 2010. |
[31] | 中华人民共和国国家药品监督管理局. 人用重组DNA制品质量控制技术指导原则. 国药监注〔2003〕109号. 2003-03-20. |
[32] |
Li F, Xu M, Zhou L, et al. Safety of Recombinant Fusion Protein ESAT6-CFP10 as a Skin Test Reagent for Tuberculosis Diagnosis: an Open-Label, Randomized, Single-Center Phase I Clinical Trial. Clin Vaccine Immunol, 2016,23(9):767-773. doi: 10.1128/CVI.00154-16.
doi: 10.1128/CVI.00154-16 URL pmid: 27413070 |
[33] |
Li F, Xu M, Qin C, et al. Recombinant fusion ESAT6-CFP10 immunogen as a skin test reagent for tuberculosis diagnosis: an open-label, randomized, two-centre phase 2a clinical trial. Clin Microbiol Infect, 2016,22(10):889.e9-889.e16. doi: 10.1016/j.cmi.2016.07.015.
doi: 10.1016/j.cmi.2016.07.015 URL |
[1] | JIN Hong-jian. The construction of tuberculosis prevention and control service system at county level in China needs to be strengthened urgently —— Comments and suggestions of an old tuberculosis control and prevention worker [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 896-902. |
[2] | LI Ting, HE Jin-ge, SU Qian, LI Jing, LI Yun-kui, GAO Wen-feng, GAO Yuan, YANG Wen. Value of tuberculin test in screening tuberculosis infection in HIV infected/AIDS patients in Butuo County, Sichuan Province [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 931-936. |
[3] | LIANG Rui-yun, FANG Wei-jun, REN Hui-li, LI Hui-ru, ZHANG Hui. Study on CT manifestations of non-tuberculous mycobacterium pulmonary disease patients with and without diabetes mellitus [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 962-967. |
[4] | Beijing Chest Hospital, Capital Medical University, Non-tuberculous Mycobacterial Branch of the Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis . Expert consensus on off-label use of drugs for non-tuberculous mycobacteria [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 769-787. |
[5] | ZHU Li-mei, CHEN Can-can, CHEN Wei, HU Xiao-guang, ZHANG Ya-nan, MA Jun-yang. To formulate prevention and control strategy for latent tuberculosis infection population in China [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 794-798. |
[6] | ZHANG Kai, SHEN Xiao-bing, TAO Li-feng, WEI Fen, CHEN Bao-wen, QIU Jing-jing, CHEN Wei, LU Jin-biao, ZHU Yin-meng, CHENG Xing, ZHONG Zai-xin, ZHAO Ai-Hua, PU Jiang. Establishment of quality standards for recombinant Mycobacterium tuberculosis fusion protein [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 814-820. |
[7] | ZHAO Ai-hua, KANG Wan-li, WANG Guo-zhi, GAO Zheng-lun, DU Wei-xin, LU Jin-biao, SHEN Xiao-bing, SU Cheng, XU Miao, ZHENG Su-hua. Screening for latent tuberculosis infection and identification of BCG vaccination by recombinant Mycobacterium tuberculosis 11 kDa [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 821-825. |
[8] | CHEN Ning, SUN Lin, SHEN A-dong, HE Qiu-shui. Possible causes of infection after BCG vaccination [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 869-873. |
[9] | ZENG Yi, GAO Wei-wei, GONG Su-gang, HOU Dai-lun. Analysis on clinical diagnosis and treatment of two cases with mediastinal fibrosis caused by tuberculosis infection [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 747-751. |
[10] | SONG Qi-sheng, LU Xi-wei. Progress and prospect of positron emission computed tomography applied in clinical research of pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(6): 621-625. |
[11] | REN Zhe-wen, ZHANG Guo-long, GONG De-hua, LEI Rong-rong, ZU Xiao-wen, XU Cai-hong, XIA Yin-yin, ZHANG Can-you, CHEN Hui, CHENG Jun, ZHANG Hui. Acceptability of preventive treatment with 12-week regimen among close contacts of tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(5): 503-509. |
[12] | LU Peng,CHENG Jun,LU Xi-wei,LIU Er-yong,ZHOU Lin,LU Wei. Scientific preventive treatment to accelerate the process of tuberculosis control [J]. Chinese Journal of Antituberculosis, 2020, 42(4): 316-321. |
[13] | FAN Xin-xin,WU Di,LIN You-fei,CHEN Xiao-hong. Disseminated tuberculosis induced by adalimumab in the treatment of ankylosing spondylitis: one case report and literature review [J]. Chinese Journal of Antituberculosis, 2020, 42(4): 391-397. |
[14] | YANG Cheng-qing,DU Rong-hui,CAO Tan-ze,ZHOU Meng,MEI Chun-lin,CHEN Shu-fang,OU Jia-li. Clinical and CT characteristic of adrenal tuberculosis complicated with Addison’s disease [J]. Chinese Journal of Antituberculosis, 2020, 42(3): 276-281. |
[15] | WANG Jing,ZHANG Meng,HE Jian-qing. Clostridium difficile-associated diarrhea caused by anti-tuberculosis drugs: a case report and literature review [J]. Chinese Journal of Antituberculosis, 2020, 42(3): 293-296. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||